FNYS
BSTC

First New York Securities’s BioSpecifics Technologies Corp. BSTC Stock Holding History

First New York Securities’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-3,000
Closed -$58K – 412
2013
Q3 		$58K Buy
+3,000
New +$53.2K 0.02% 271

Other funds holding BSTC

BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
MOACM
Mutual of America Capital Management New York $8.8B AUM 29.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

First New York Securities's BSTC Position: Q4 2013 in Review

First New York Securities sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2013, closing a stake of 3,000 shares — an estimated $58K sold.

First New York Securities first reported a position in BSTC in Q3 2013 and held it in 1 quarter. The position peaked at $58K in Q3 2013. 38 funds tracked by Wall St. Rank hold BSTC as of Q4 2013.

  • First New York Securities reported no remaining BioSpecifics Technologies Corp. position as of Q4 2013 after selling out during the quarter.
  • First New York Securities sold 3,000 BioSpecifics Technologies Corp. shares in Q4 2013, an estimated $58K.
  • First New York Securities first reported a position in BioSpecifics Technologies Corp. in Q3 2013 and held it in 1 quarter.
  • First New York Securities's BioSpecifics Technologies Corp. position peaked at $58K in Q3 2013.
  • 38 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2013.

Based on First New York Securities's 13F filing for Q4 2013, filed 12 Feb 2014.